Patient-Centered Thinking and Achieving Optimal Outcomes in Patients with UC: A Care Team Forum®

Program Overview

Join Drs. Long and Dulai, nurse Schwab, and an experienced patient with ulcerative colitis (UC) as they highlight challenges in UC care from an interprofessional team perspective. During this activity you will learn how to apply a treat-to-target approach, select biologics based on real-world evidence, use clinical decision support tools, and optimize shared decision making for improved outcomes in patients with UC.

Credit Expired

1.00 CE Credit(s)

Expires: July 14, 2023

Target Audience

This activity is intended for gastroenterologists, GI surgeons, nurses, and other GI-focused clinicians who manage patients with ulcerative colitis (UC).

Educational Objectives

Upon completion of this activity, participants should be better able to:

Implement the treat-to-target approach for managing patients with ulcerative colitis (UC)
Select biologics for the treatment of UC using support tools in combination with evidence-based findings
Integrate the unique roles of the interprofessional care team when engaging in shared decision making for optimal management of UC

Activity Faculty

Millie D. Long, MD, MPH

Professor, Medicine
Director, Gastroenterology and Hepatology Fellowship Program
Vice-Chief, Education
University of North Carolina at Chapel Hill
Chapel Hill, NC

Parambir S. Dulai, MD

Associate Professor, Medicine
Director, GI Clinical Trials
Director, Precision Medicine
Division of Gastroenterology & Hepatology
Feinberg School of Medicine, Northwestern University
Evanston, IL

Kari Schwab, RN, BSN

UNC IBD Nurse Coordinator
Division of Gastroenterology and Hepatology
University of North Carolina at Chapel Hill
Chapel Hill, NC

Provider Statement

This activity is provided by RMEI Medical Education, LLC

Supporter Statement

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 